Holles Natalie C.
- SEC CIK
- 0001580111
No open-market purchases or sales filed in the past year.
Current role at each company
- LONA LeonaBio, Inc.Directoras of Jun 24, 2026
- AURA Aura Biosciences, Inc.See Remarksas of May 19, 2026
- DAWN Day One Biopharmaceuticals, Inc.Directoras of Apr 23, 2026
- THRD Third Harmonic Bio, Inc.CEOas of Aug 14, 2025
- RUBY Rubius Therapeutics, Inc.Directoras of May 13, 2022
Show 1 more company
- ALLK Allakos Inc.Directoras of Oct 14, 2021
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Holles Natalie C. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
THRD Third Harmonic Bio, Inc.
CEO2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 10, 2024 (view filing) | May 9 | 1 day | Holles Natalie C.CEO | SSale | −20.2K | $12.18 | −$246.3K | −1.6%1.22M after | 10b5-1 |
| Apr 15, 2024 (view filing) | Apr 11 | 4 days | Holles Natalie C.CEO | SSale | −13.6K | $12.19 | −$165.3K | −1.1%1.22M after | 10b5-1 |